|4Jun 14, 7:34 PM ET

LAZARUS ROCHELLE B 4

4 · Organon & Co. · Filed Jun 14, 2022

Insider Transaction Report

Form 4
Period: 2022-06-10
Transactions
  • Award

    Phantom Stock

    2022-06-10$35.46/sh+5,640$199,99414,638 total
    Common Stock (5,640 underlying)
Holdings
  • Common Stock

    458
  • Common Stock

    (indirect: By Spouse)
    175
Footnotes (4)
  • [F1]The number of shares of Organon & Co. ("Organon") common stock previously reported has been adjusted based on the finalization of certain calculations in connection with the separation of Organon from Merck & Co., Inc.
  • [F2]Each phantom stock unit is an economic equivalent of one share of Organon common stock, or 1-for-1.
  • [F3]Phantom stock units are granted under the Organon Non-Employee Director Savings Plan (the "Plan") and are payable in cash upon settlement after the reporting person's termination of service as a director pursuant to the terms of the Plan.
  • [F4]Holdings include phantom stock acquired in dividend reinvestment transactions on September 13, 2021, December 16, 2021 and March 17, 2022.

Documents

1 file
  • 4
    tm2218336-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT